Most Recent Articles by Bryant Furlow
Targeted and immunotherapies appear to be opening a new frontier in the management of elderly patients.
Technical standardization and development of the International Scale for reporting Philadelphia chromosome BCR-ABL1 fusion gene expression has improved consistency.
Breast cancer subtype influences the probability that a patient has brain metastases at the time of diagnosis.
Can liquid biopsy and molecular imaging biomarkers help inform more precise management of patients with metastatic prostate cancer?
Clinical trial investigators who receive drug industry funding are about 3.5 times as likely to find positive results as trials led by scientists who did not receive industry payments.
More Articles by Bryant Furlow
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|